The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?
Section snippets
Acknowledgements
This research was supported in part by Russian Academy of Medical Sciences and Senetek, PLC. The preliminary account of this paper was presented at the Society for Neuroscience (USA) Annual Meeting, New Orleans, LA, USA, on November 5, 2000.
References (30)
- et al.
Cholinergic stimulation of hippocampal pyramidal cells is inhibited by increasing membrane cholesterol
Brain Res.
(1983) - et al.
Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease
J. Lipid. Res.
(2000) - et al.
Advances in understanding of the role of lecithin:cholesterol acyltransferase (LCAT) in cholesterol transport
Clin. Chim. Acta
(1999) - et al.
Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
Free Rad. Biol. Med.
(2001) - et al.
The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein and very high density lipoprotein in normal human plasma
Biochem. Biophys. Res. Commun.
(1994) - et al.
Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins
Biochem. Biophys. Res. Commun.
(1996) - et al.
Soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein
Cell. Biol. Int.
(1997) - et al.
High-density lipoprotein cholesterol in differential diagnosis of senile dementia
Lancet
(1985) - et al.
Uptake of lipoproteins for axonal growth of sympathetic neurons
J. Biol. Chem.
(2000) - et al.
Alterations in apoE and apoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion
Exp. Neurol.
(2001)
Competition of Abeta amyloid peptide and apolipoprotein E receptor-mediated endocytosis
J. Lip. Res.
(1999)
Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease
Dement. Geriatr. Cogn. Disord.
(2000)
Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype
Ann. Neurol.
(2000)
Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluid
J. Neurochem.
(1998)
Alzheimer's peptides Aβ1-40 and Aβ1-28 inhibit the plasma cholesterol esterification rate
Biochem. Mol. Biol. Inter.
(1996)
Cited by (0)
Copyright © 2001 Elsevier Science Ireland Ltd. All rights reserved.